3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
6
Endocrine
6
Thoracic
1
Sarcoma
1
NET
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
349
Triple Negative Breast Neoplasms
59
Ovarian Neoplasms
43
Colorectal Neoplasms
34
Prostatic Neoplasms
32
Carcinoma, Non-Small-Cell Lung
25
Neoplasms
24
Endometrial Neoplasms
23
Neoplasm Metastasis
19
Lung Neoplasms
17
Uterine Cervical Neoplasms
16
Stomach Neoplasms
16
Melanoma
16
Squamous Cell Carcinoma of Head and Neck
15
Pancreatic Neoplasms
15
Carcinoma, Renal Cell
14
Urinary Bladder Neoplasms
12
Head and Neck Neoplasms
11
Sarcoma
10
Esophageal Neoplasms
10
Small Cell Lung Carcinoma
8
Colonic Neoplasms
8
Kidney Neoplasms
7
Advanced Breast Cancer
7
Liver Neoplasms
6
Cholangiocarcinoma
6
Carcinoma, Transitional Cell
6
Carcinoma, Hepatocellular
6
Brain Neoplasms
6
Anatomic Stage I Breast Cancer AJCC v8
6
Interventions
entrectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thyroid Cancer, Papillary
×
Breast
×
30 days
×
Clear all
NCT02568267
2026-05-27
STARTRK-2
Hoffmann-La Roche
Phase 2
Active not recruiting
534 enrolled
1 FDA